Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully

(2017) William H. Polonsky et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

(2017) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial

(2017) John Furler et al.   BMJ-British Medical Journal

Clinical inertia to insulin initiation and intensification in the UK: A focused literature review

(2017) Kamlesh Khunti et al.   Primary Care Diabetes

Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial

(2017) John Furler et al.   BMJ-British Medical Journal

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) – DEVOTE 1

(2016) Steven P. Marso et al.   AMERICAN HEART JOURNAL

Safety and Efficacy of a Pragmatic Self-Titration 1 Unit/Day (INSIGHT) Algorithm for Insulin Glargine 300 U/mL (Gla-300)

(2016) Lori Berard et al.   Canadian Journal of Diabetes

New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?

(2016) Eberhard Standl et al.   DIABETES CARE

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)

(2016) M. Matsuhisa et al.   DIABETES OBESITY & METABOLISM

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)

(2016) Y. Terauchi et al.   DIABETES OBESITY & METABOLISM

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

(2016) Matthew C. Riddle et al.   Diabetes Technology & Therapeutics

Insulin glargine 300U/ml in the management of diabetes: clinical utility and patient perspectives

(2016) Bastiaan de Galan   Patient Preference and Adherence

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

(2015) Philip D. Home et al.   DIABETES CARE

Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes

(2015) R. Ritzel et al.   DIABETES OBESITY & METABOLISM

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

(2015) G. B. Bolli et al.   DIABETES OBESITY & METABOLISM

Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review

(2015) C. J. Ng et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Identifying the worries and concerns about hypoglycemia in adults with type 2 diabetes

(2015) W.H. Polonsky et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

(2014) Matthew C. Riddle et al.   DIABETES CARE

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

(2014) Hannele Yki-Järvinen et al.   DIABETES CARE

New Insulin Glargine 300 units{middle dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 units{middle dot}mL-1

(2014) R. H. A. Becker et al.   DIABETES CARE

Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml

(2014) A. Steinstraesser et al.   DIABETES OBESITY & METABOLISM

Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use)

(2013) Athena Philis-Tsimikas et al.   ADVANCES IN THERAPY

The Early Treatment of Type 2 Diabetes

(2013) Richard E. Pratley   AMERICAN JOURNAL OF MEDICINE

Breaking Down Patient and Physician Barriers to Optimize Glycemic Control in Type 2 Diabetes

(2013) Stuart A. Ross   AMERICAN JOURNAL OF MEDICINE

Psychosocial Issues in Diabetes Self-Management: Strategies for Healthcare Providers

(2013) Brigitte C. Sabourin et al.   Canadian Journal of Diabetes

Table of Contents

(2013)   Canadian Journal of Diabetes

Type 2 Diabetes Mellitus Management in Canada: Is It Improving?

(2013) Lawrence A. Leiter et al.   Canadian Journal of Diabetes

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

(2013) R. A. DeFronzo et al.   DIABETES CARE

Clinical Inertia in People With Type 2 Diabetes: A retrospective cohort study of more than 80,000 people

(2013) K. Khunti et al.   DIABETES CARE

The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes

(2013) L. Meneghini et al.   DIABETES CARE

Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes

(2013) Stephen C.L. Gough et al.   DIABETES CARE

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

(2013) E. R. Seaquist et al.   DIABETES CARE

Will the next generation of basal insulins offer clinical advantages?

(2013) A. J. Garber   DIABETES OBESITY & METABOLISM

Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes

(2013) David R. Owens   Diabetes Technology & Therapeutics

Basal insulin analogues in the management of diabetes mellitus: what progress have we made?

(2013) David R. Owens et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Diabetes Attitudes, Wishes and Needs second study (DAWN2™): Cross-national benchmarking indicators for family members living with people with diabetes

(2013) K. Kovacs Burns et al.   DIABETIC MEDICINE

Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review

(2013) M. J. Davies et al.   DIABETIC MEDICINE

Insulin Stacking Versus Therapeutic Accumulation: Understanding the Differences

(2013) Tim Heise et al.   Endocrine Practice

Clinical inertia—a barrier to effective management of T2DM

(2013) Julie A. Lovshin et al.   Nature Reviews Endocrinology

Insulin degludec compared with insulin glargine in insulin-naïve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial

(2013) Yukiko Onishi et al.   Journal of Diabetes Investigation

Pharmacist intervention for glycaemic control in the community (the RxING study)

(2013) Yazid N Al Hamarneh et al.   BMJ Open

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

(2012) B. Zinman et al.   DIABETES CARE

Barriers to Insulin Progression Among Patients With Type 2 Diabetes

(2012) Jennifer M. Polinski et al.   DIABETES EDUCATOR

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes

(2012) T. Heise et al.   DIABETES OBESITY & METABOLISM

Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care

(2012) Mark Peyrot et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

(2012) M. Peyrot et al.   DIABETIC MEDICINE

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

(2012) Alan J Garber et al.   LANCET

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine

(2011) J. B. Buse et al.   DIABETES CARE

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study

(2010) S. Arnolds et al.   DIABETES CARE

Barriers to Insulin Initiation: The Translating Research Into Action for Diabetes Insulin Starts Project

(2010) A. J. Karter et al.   DIABETES CARE

Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)

(2010) Bernard Charbonnel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATETMstudy

(2009) L. Blonde et al.   DIABETES OBESITY & METABOLISM

Barriers to insulin initiation and intensification and how to overcome them

(2009) T. Kunt et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adjust to Target in Type 2 Diabetes: Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine

(2008) R. M. Bergenstal et al.   DIABETES CARE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE